| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 3.600 | 2.698 | 741 | 0 | 0 | - | - |
| Total Income - EUR | 0 | 0 | 0 | 3.600 | 2.698 | 741 | 0 | 0 | - | - |
| Total Expenses - EUR | 2.711 | 1.927 | 2.692 | 3.556 | 4.965 | 4.829 | 4.730 | 5.373 | - | - |
| Gross Profit/Loss - EUR | -2.711 | -1.927 | -2.692 | 44 | -2.267 | -4.089 | -4.730 | -5.373 | - | - |
| Net Profit/Loss - EUR | -2.711 | -1.927 | -2.692 | -37 | -2.348 | -4.111 | -4.730 | -5.373 | - | - |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - |
Check the financial reports for the company - Doimed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 60.470 | 59.854 | 58.841 | 56.921 | 54.408 | 51.992 | 49.485 | 48.280 | - | - |
| Current Assets | 28.338 | 28.822 | 28.318 | 28.099 | 27.255 | 26.749 | 26.146 | 26.237 | - | - |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - |
| Receivables | 28.328 | 28.822 | 28.318 | 27.798 | 27.242 | 26.739 | 26.146 | 26.227 | - | - |
| Cash | 10 | 0 | 0 | 301 | 13 | 10 | 0 | 10 | - | - |
| Shareholders Funds | -9.174 | -11.008 | -13.513 | -13.302 | -15.419 | -19.238 | -23.541 | -28.987 | - | - |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | - | - |
| Debts | 97.982 | 99.684 | 100.672 | 98.323 | 97.083 | 97.979 | 99.172 | 103.505 | - | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6820 - 6820" | |||||||||
| CAEN Financial Year |
6820
|
|||||||||
Comments - Doimed Srl